US Stock MarketDetailed Quotes

CytoMed Therapeutics (GDTC)

Watchlist
  • 1.000
  • -0.030-2.91%
Close Aug 24 16:00 ET
  • 0.955
  • -0.045-4.46%
Post 18:34 ET
11.83MMarket Cap-3.73P/E (TTM)

CytoMed Therapeutics (GDTC) Balance Sheet

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: SGD
2025/Q4
2025/Q2
2024/Q4
2024/Q2
2023/Q4
2023/Q2
2022/Q4
2022/Q2
2021/Q4
Total Assets
-20.69%7.98M
-23.40%8.36M
-18.60%10.07M
-21.60%10.91M
+136.63%12.37M
+170.01%13.91M
-14.06%5.23M
--5.15M
--6.08M
Total Current Assets
-38.96%3.66M
-47.02%4.08M
-40.57%6.00M
-32.80%7.71M
+304.86%10.10M
+421.47%11.47M
-24.01%2.49M
--2.20M
--3.28M
Cash and Cash Equivalents & Short-Term Investments
-57.84%2.10M
-55.89%2.85M
-44.74%4.97M
-38.00%6.47M
+469.41%9.00M
+601.86%10.44M
-37.13%1.58M
--1.49M
--2.51M
-Cash and Cash Equivalents
-57.84%2.10M
-55.89%2.85M
-44.74%4.97M
-38.00%6.47M
+469.41%9.00M
+601.86%10.44M
-37.13%1.58M
--1.49M
--2.51M
Receivables
+8.95%132.05K
+252.11%171.97K
-40.80%121.21K
-32.48%48.84K
+255.58%204.75K
+445.35%72.34K
+988.51%57.58K
--13.26K
--5.29K
-Accounts Receivable
+452.97%103.86K
--24.71K
--18.78K
----
--0.00
----
----
----
----
-Accrued Interest Receivable
-96.87%1.14K
+65.62%52.14K
-80.50%36.41K
--31.48K
--186.73K
----
----
----
----
-Taxes Receivable
+81.40%5.25K
--16.39K
-38.60%2.89K
----
--4.71K
----
----
--4.02K
----
-Due from Related Parties Current
----
----
----
----
----
----
----
--0.00
--1.26K
-Other Receivables
-65.45%21.81K
+353.63%78.72K
+374.32%63.12K
-76.01%17.35K
-76.89%13.31K
+682.85%72.34K
+1328.48%57.58K
--9.24K
--4.03K
Prepaid Assets
+57.89%1.44M
-11.03%1.06M
+1.37%909.13K
+29.58%1.19M
+4.70%896.82K
+31.08%916.12K
+12.16%856.56K
--698.91K
--763.69K
Other Current Assets
----
----
----
----
----
--42.60K
----
----
----
Total Non-Current Assets
+6.27%4.32M
+33.47%4.27M
+78.99%4.07M
+30.91%3.20M
-16.87%2.27M
-17.20%2.45M
-2.41%2.73M
--2.95M
--2.80M
Net PPE
+13.48%3.69M
+40.02%3.47M
+57.55%3.25M
+12.09%2.48M
-16.57%2.06M
-17.57%2.21M
-0.83%2.47M
--2.68M
--2.50M
-Gross PPE
+17.51%5.90M
----
+46.38%5.02M
----
-2.78%3.43M
----
+9.10%3.53M
--3.58M
--3.23M
-Accumulated Depreciation
-24.93%-2.21M
----
-29.47%-1.77M
----
-29.63%-1.36M
----
-42.71%-1.05M
---898.01K
---737.67K
Investments and Advances
-91.76%18.21K
+8.32%228.56K
+13.27%220.95K
-3.94%211.01K
-18.52%195.07K
-10.10%219.67K
-12.29%239.42K
--244.35K
--272.97K
-Available for Sale Securities
--18.21K
----
----
----
----
----
----
----
----
-Long Term Equity Investment
-100.00%0.00
-0.31%210.35K
+13.27%220.95K
-3.94%211.01K
-18.52%195.07K
-10.10%219.67K
-12.29%239.42K
--244.35K
--272.97K
Non Current Accounts Receivables
-2.54%487.28K
+0.00%500.00K
--500.00K
--500.00K
----
----
----
----
----
Goodwill and Other Intangible Assets
+34.22%124.89K
+558.88%72.56K
+649.62%93.05K
-20.29%11.01K
-34.00%12.41K
-45.64%13.82K
-41.26%18.81K
--25.41K
--32.02K
-Goodwill
+0.00%355.00
+0.00%355.00
+0.00%355.00
+0.00%355.00
+0.00%355.00
+0.00%355.00
+0.00%355.00
--355.00
--355.00
-Other Intangible Assets
+34.35%124.54K
+577.50%72.20K
+668.74%92.70K
-20.82%10.66K
-34.66%12.06K
-46.28%13.46K
-41.73%18.45K
--25.06K
--31.67K
Total Liabilities
+10.48%1.13M
+51.55%1.13M
-8.96%1.02M
+0.37%748.82K
-75.76%1.12M
-79.24%746.07K
+32.94%4.64M
--3.59M
--3.49M
Total Current Liabilities
+16.90%709.17K
+96.44%703.09K
-15.39%606.62K
+13.67%357.92K
-82.79%716.94K
-89.76%314.88K
+41.84%4.17M
--3.07M
--2.94M
Payables
+148.24%188.47K
+201.49%209.18K
+1.17%75.93K
-10.54%69.38K
-57.48%75.05K
-36.79%77.55K
+169.23%176.48K
--122.69K
--65.55K
-Accounts Payable
+222.89%124.74K
+84.54%82.74K
+56.93%38.63K
-27.05%44.83K
+68.29%24.62K
-13.16%61.46K
-68.37%14.63K
--70.77K
--46.25K
-Total Tax Payable
--2.66K
----
--0.00
----
-100.00%0.00
--1.52K
--1.60K
----
--0.00
-Due to Related Parties Current
----
----
----
----
-100.00%0.00
-100.00%0.00
+0.00%1.27K
--1.27K
--1.27K
-Other Payable
+63.78%61.08K
+415.09%126.44K
-26.05%37.29K
+68.38%24.55K
-68.28%50.43K
-71.22%14.58K
+781.44%159.00K
--50.66K
--18.04K
Current Accrued Expenses
-30.61%252.38K
+9.28%264.00K
-18.57%363.69K
+29.39%241.57K
+89.32%446.63K
+106.55%186.70K
+63.03%235.91K
--90.39K
--144.70K
Short-Term Debt and Capital Lease Obligation
+31.65%60.45K
+54.68%57.84K
+14.07%45.91K
-8.73%37.39K
-98.92%40.25K
-98.56%40.96K
+38.44%3.74M
--2.84M
--2.70M
-Current Debt
+8.49%40.85K
+9.88%38.26K
+10.98%37.65K
+4.08%34.82K
-99.09%33.93K
-98.82%33.46K
+38.55%3.74M
--2.83M
--2.70M
-Current Capital Lease Obligation
+137.21%19.60K
+663.00%19.57K
+30.65%8.26K
-65.83%2.57K
-17.98%6.32K
-3.86%7.51K
-1.32%7.71K
--7.81K
--7.81K
Current Deferred Liabilities
+67.48%182.81K
+775.31%83.81K
+1199.40%109.15K
-0.92%9.58K
-7.73%8.40K
-52.04%9.66K
-58.57%9.10K
--20.15K
--21.97K
Other Current Liabilities
+109.83%25.06K
--88.27K
-91.85%11.95K
----
--146.61K
----
----
----
----
Total Non-Current Liabilities
+1.15%422.12K
+10.46%431.77K
+2.35%417.34K
-9.35%390.90K
-14.25%407.77K
-17.01%431.20K
-14.23%475.54K
--519.58K
--554.44K
Long Term Debt and Capital Lease Obligation
+1.15%422.12K
+10.46%431.77K
+2.35%417.34K
-9.35%390.90K
-14.25%407.77K
-17.01%431.20K
-14.23%475.54K
--519.58K
--554.44K
-Long Term Debt
-6.51%368.66K
-4.71%372.50K
-3.30%394.31K
-8.80%390.90K
-13.02%407.77K
-15.72%428.61K
-13.04%468.83K
--508.58K
--539.12K
-Long Term Capital Lease Obligation
+132.16%53.46K
--59.27K
--23.03K
-100.00%0.00
-100.00%0.00
-76.53%2.58K
-56.20%6.71K
--11.00K
--15.32K
Total Equity
-24.22%6.85M
-28.92%7.22M
-19.57%9.04M
-22.84%10.16M
+1817.82%11.24M
+744.70%13.17M
-77.38%586.30K
--1.56M
--2.59M
Stockholders' Equity
-27.01%6.54M
-29.67%7.15M
-20.27%8.97M
-22.84%10.16M
+1815.76%11.25M
+744.45%13.17M
-77.35%586.98K
--1.56M
--2.59M
Capital Stock
+3.63%24.66M
+0.00%23.79M
+0.31%23.79M
+0.31%23.79M
+166.13%23.72M
+208.44%23.72M
+36.10%8.91M
--7.69M
--6.55M
-Common Stock
+3.63%24.66M
+0.00%23.79M
+0.31%23.79M
+0.31%23.79M
+166.13%23.72M
+208.44%23.72M
+36.10%8.91M
--7.69M
--6.55M
Retained Earnings
-26.81%-18.83M
-27.36%-17.09M
-20.41%-14.85M
-29.58%-13.42M
-50.41%-12.33M
-70.83%-10.36M
-61.79%-8.20M
---6.06M
---5.07M
Gains/Losses Not Affecting Retained Earnings
+2890.87%604.90K
+98.49%-3.21K
+109.30%20.23K
-9.45%-212.01K
-70.53%-217.40K
-184.06%-193.70K
-311.50%-127.48K
---68.19K
---30.98K
Other Equity Interests
--111.23K
--447.68K
----
----
--73.93K
----
----
----
--1.14M
Minority Interests
+297.72%309.22K
+6973.84%75.68K
+8232.74%77.75K
-33.94%-1.10K
-40.18%-956.00
-51.38%-822.00
-55.35%-682.00
---543.00
---439.00
Deadline
Dec 31, 2025
Jun 30, 2025
Dec 31, 2024
Jun 30, 2024
Dec 31, 2023
Jun 30, 2023
Dec 31, 2022
Jun 30, 2022
Dec 31, 2021
Accounting Standard
--
--
--
--
--
--
--
--
--
2025/Q42025/Q22024/Q42024/Q22023/Q42023/Q22022/Q42022/Q22021/Q4
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On August 24 (U.S. Eastern Time), U.S. Treasury Secretary Bessent announced "unprecedented" economic actions against Iran, aiming to sever i Show More